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HPLCAbstract The present report is about Streptomyces sp. isolate ERI-26 isolated from the soil sample
of Nilgiri forest, Western Ghats. The methanol extract of ERI-26 showed good antimicrobial
activity against tested microbes. The antimicrobial novel anthraquinones were purified by
bioactivity-guided fractionation using a silica gel column and preparative HPLC. The compound
was characterized and identified by UV, IR, NMR and MASS spectral data. The compound named
as 6,61-bis (1,5,7-trihydroxy-3-hydroxymethylanthraquinone), showed significant antimicrobial
activities against tested microbes. The isolated compound inhibited the tested bacterial growth,
Staphylococcus aureus at 62.5 lg/ml, Staphylococcus epidermidis at 15.62 lg/m, Bacillus subtilis at
62.5 lg/ml, fungi; Trichophyton mentagrophytes at 15.62 lg/m Trichophyton simii at 15.62 lg/ml,
Aspergillus niger at. 7.81 lg/ml, Aspergiller flavus at 3.90 lg/ml, Trichophyton rubrum 296 at
62.5 lg/ml, T. rubrum 57/01 at 7.81 lg/ml, Magnaporthe grisea at 15.62 lg/ml. and Botrytis cinerea
at 3.90 lg/ml. Isolated anthraquinone compound and its antimicrobial activity were newly reported.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The emerging microbial infection and drug resistant pathogens
are creating a major health problem throughout the world. In
order to rectify these problems, searching for an effective, new
antibiotic compound with significant drug mode of action is
very important. The secondary metabolites from actino-
mycetes, particularly the members those belonging to the phy-
lum Actinobacteria are having a wide variety of chemical
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et al., 2010). Streptomyces is GC rich, Grampositive, filamen-
tous member of the phylum, Actinobacteria and it produces
many pharmaceutically important secondary metabolites such
as therapeutic enzymes, antibiotics, immunosuppressants, anti
tumour agents and vitamins (Watve et al., 2001). Actino-
mycetes are usually Gram-positive bacteria containing a per-
centage of guanine, cytosine higher than 55%, and most of
actinomycetes produce mycelia. The actinomycetes are very
interesting due to their ability to synthesize biologically active
metabolites with diverse chemical molecules. (Valan Arasu
et al., 2008). Streptomycetes especially the genus Streptomyces
were very potent producers of secondary metabolites including
antibacterial enzymes and toxins (Ren et al., 2010). Major
types of antibiotics produced by Streptomyces are aminoglyco-
sides, anthracyclines, glycopeptides, b-lactams, macrolides,
nucleosides, peptides, polyenes, polyethers, and antetracyclines
(Miyadoh, 1993). The widespread use of antibiotics in medi-
cine plays a significant role in the emergence of resistant bac-
teria and specifically, misuse and/or overuse of antibiotics
are the major causes (Mathew et al., 2007; Ferber, 2002;
Goossens et al., 2005).
The actinomycete class produces novel secondary metabo-
lites, and sometimes very unique metabolites which signifi-
cantly show biological activities with low toxicity (Berdy,
2005; Kurtbo¨ke, 2012). Most of the antimicrobial compounds
have been isolated and characterized from actinomycete group
including anthracyclines, aminoglycosides, macrolides, gly-
copeptides, nucleosides, beta-lactams, peptides, polyketides,
tetracyclines and actinomycins by Berdy (2005).
Number of antibiotics are isolated from extracellular of
microbes which are diffused in culture media (Bode et al.,
2002;Charoensopharat et al., 2008). The present studies are
aimed to isolate the novel molecule from Streptomyces sp.
ERI-26 and tested against pathogenic bacteria and fungi.
2. Materials and methods
2.1. Isolation and identification
The isolation and identification of selected Streptomyces iso-
late. ERI-26 have been reported in our earlier article (Valan
Arasu et al., 2008).
2.2. Chemical
The pure organic solvents were used in this experiment. Hex-
ane, ethyl acetate and methanol solvents were purchased from
Ranbaxy laboratory, Saidapet, Chennai-15. The Silica gel was
purchased from Merck (NJ, USA), which is used for thin layer
chromatography (TLC) and column chromatography. All
other chemicals were pure grade.
2.3. Extract preparation and isolation of active fraction by
column chromatography
The isolate Streptomyces sp. isolate ERI-26 was grown in
MNGA agar media and kept for incubation for 6 days. After
the incubation period the culture with agar media was put into
500 ml of methanol in a conical flask. The content was allowedto diffuse the compounds in methanol. After that it was sub-
jected to centrifuge (4000 rpm, 10 min) and extract was taken
in methanol. The methanol phase was evaporated using vac-
uum rotary evaporator. Finally crude extract was obtained.
The extract 5.25 g was subjected to fractionation using silica
gel column chromatography. Totally 12 fractions were col-
lected using the solvent system of chloroform, ethylacetate
and methanol and their mixture. The active fraction 5 was
taken for further isolation of active compound.
2.4. Reversed-phase high performance liquid chromatography
(RPHPLC) purification
The 5th fraction yielded 5 g. The fraction 5 was further purified
with the help of preparative HPLC with an isocratic elution
capability, ultraviolet spectrophotometer as detector and an
auto sampler (Waters Alliance System). The purification of
5th fraction in preparative HPLC the solvent system were used:
acetonitrile and aqueous acetic acid (15:85, v/v). The flow-rate
was 3 ml/min and sample injection volume was 100 ll. The
fraction was monitored on the screen also at 254 nm and the
peak fraction was carefully collected. The fraction 5 was puri-
fied as two fractions. The second fraction B was taken for fur-
ther structure elucidation which is shown in HPLC 99.14%.
2.5. Identification and characterization of anthraquinone by
spectroscopic method
Fraction B was obtained from fraction 5 using preparative
HPLC method. Fraction B was submitted to spectroscopic
analysis. The 1H NMR (300 MHz), (AL-300 JEOL) spectra
were measured and 13C NMR, AL-300 JEOL spectra were
measured on a (75.45 MHz). The mass spectrum of the isolated
compound (ESI-MS-JEOL instrument) was taken, IR spec-
trum of the isolated compound was taken from Shimadzu by
KBr pellet method.
2.6. Tested microorganisms
The present study was antimicrobial screening of isolated com-
pound B against following pathogenic microbes; Bacteria:
Enterococcus faecalis ATCC 29212, Bacillus subtilis MTCC
441, Staphylococcus aureus ATCC 25923, Escherichia coli
ATCC 25922, Staphylococcus epidermidis MTCC 3615, Kleb-
siella pneumoniae ATCC 15380, Pseudomonas aeruginosa
ATCC 27853, Proteus vulgarisMTCC 1771. Fungi: Trichophy-
ton rubrumMTCC 296, Trichophyton mentagrophytes 66/01, T.
rubrum 57/01, Trichophyton simii 110/02, Aspergillus niger
MTCC 1344, Epidermophyton floccosum 73/01, Aspergillus fla-
vus, Curvularia lunata 46/0, Botrytis cinerea, Candida albicans
MTCC 227 andMagnaporthe grisea. The tested microbes were
obtained from the Institute of Microbial Technology
(IMTECH), Chandigarh, India.
2.7. Preparation of inoculums
The preparation of inoculums was followed by standard proto-
col. The bacterial cells were grown in Mueller Hinton Broth
(Himedia) for 24 h at 37 C. These cell suspensions were
diluted with sterile MHB to provide initial cell counts of about
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trose Agar (SDA) slants in suitable temperature at 28 C for
3 days. After incubation period the spores were collected from
slants using sterile DD water and homogenized. The yeast
inoculums were prepared by using Sabouraud Dextrose Broth
(SDB) at 28 C for 48 h.
2.8. Minimum inhibitory concentration
The minimum inhibitory concentration of the isolated
compound tested against microbes using standard method
for bacteria (Duraipandiyan and Ignacimuthu, 2009), fungi
(CLSI, 2008) and yeasts (NCCLS, 2002). The isolated com-
pound dissolved in suitable solvents. The concentration of
the tested compound was 250 lg/ml. This was serially diluted
twofold. The bacterial 100 ll of inoculums (108 CFU/ml) was
inoculated in each well and 104 spore/ml of fungi, respectively.
The Fluconazole for fungi and Ciprofloxacin for bacteria were
included in the assays as positive controls. The plates were
incubated in 24, 48 or 72 h at 27 C for fungi, up to 9 days
for dermatophytes. The bacterial plates were incubated for
24 h at 37 C. After the incubation period the Minimum inhi-
bitory concentration of the tested compound was observed and
the lowest extract concentration was noted , showing no visible
fungal growth after incubation time.
3. Results and discussion
3.1. Isolation and purification
Streptomyces isolate (ERI-26) methanol extract was subjected
to chromatography separation. Totally 12 fractions were col-
lected and identified by the screening method, it was reported
in our previous article (Valan Arasu et al., 2008). The active
fraction 5 was further separated and purified using semi-
preparative HPLC. This fraction gave two fractions. Both
the fractions purified and showed activity against tested
microbes. The fraction A was already published
(Duraipandiyan et al., 2014). The fraction B was presently
reported. The pure compound was purified by using prepara-
tive HPLC. The purified compound was eluted at 5.94 min
yielding 95 mg, purity was 99.14% in HPLC (Fig. 1).
3.2. Structure elucidation of compound 6,61-bis (1,5,7-
trihydroxy-3-hydroxymethylanthraquinone)
Further elution of the column with the same solvent mixture
gave compound which was crystallized as yellow orange crys-
tals from acetone (yield 82 mg, mp.293). The compound
answered for phenol and also for quinone. TLC of the isolated
compound showed single spot with ethyl acetate: methanol:
acetic acid 3:2:02 as developing system, (Rf = 0.5) turning
pink on exposure to ammonia vapour. Its molecular formula
is C30H18O12.
UV kmax MeOH nm: 222,246,272,316,439. IR cmax KBR
cm1: 3429 (hydroxyl), 2924, 2853, 1630 (chelated quinone car-
bonyl), 1609, 1570, 1450, 1386, 1363, 1421, 1257, 1224, 1100,
1082, 1063, 878, 761, 731. 1H NMR (d, DMSO-d6,
300 MHz): 7.27 (2H, brs, H-2 and H-2
0
), 7.65 (2H,brs, H4
and H-4
0
), 7.32 (2H,brs, H-8 and H-8
0
), 12.22 and 12.76 (2Heach, brs, 4 chelated OH), 11.86 (2H, brs, C-7OH and C-70
OH) 4.60 (4H, brs, 2 CH2OH). 13C NMR (d, DMSO-d6,
75 MHz): 159.52 (C-1 and C-10) 120.89 (C-2 and C-20),
153.30 (C3 and C-30), 117.22 (C-4 and C-40) 132.22 (C-4a
and C-40a), 161.45 (C-5 and C-50), 112.86 (C-6 and C-60),
160.07 (C-7 and C-70), 109.42 (C-8 and C80), 132.83 (C-8a
and C-80a), 189.86 (C-9 and C-90), 114. 09 (C-9a and C-90a),
181.01 (C-10 and C-100), 107.77 (C-10a and C-100a), 61.99
(2 CH2OH). EI-MS (m/z): 551 [M-H2O-H]+. The above
spectral data showed the compound B to be 6,61-bis (1,5,7-tri
hydroxy-3-hydroxymethylanthraquinone) which was novel
(Fig. 2).
3.3. Antimicrobial activities of compound
The compound 6,61-bis (1,5,7-trihydroxy-3-hydroxymethylan
thraquinone) was tested against bacteria and fungi. Minimum
inhibitory concentration values for the compound are reported
in Table 1. The compound (6,61-bis (1,5,7-trihydroxy-3-hydro
xymethylanthraquinone) inhibited the growth of S. aureus
at 62.5 lg/ml, S. epidermidis at 15.62 lg/ml, B. subtilis at
62.5 lg/ml, E. faecalis at 62.5 lg/ml and P. aeruginosa at
150 lg/ml. Fungi: T. mentagrophytes at 15.62 lg/ml, E. flocco-
sum at 125 lg/ml, T. simii at 15.62 lg/ml, T. rubrum296 at
62.5 lg/ml, T. rubrum 57 at 7.81 lg/ml, A. niger at 7.81 lg/ml,
A. flavus at 3.90 lg/ml, B. cinerea 3.90 lg/ml and M. grisea
at 15.62 lg/ml. (Table 1). The significant MIC values of tested
anthraquinone showed against A. flavus and B. cinerea.
Above isolated compound spectral data showed anthraqui-
none skeleton. The spectral data closely resembled to that of
citreorosein (x-hydroxyl emodin) an anthraquinone isolated
from plants and fungi (Fujimoto et al., 2004). Compound
was isolated as yellow orange crystals from acetone (m.p.
293); it showed the molecular formula as C30H18O12 based
on mass, 1H and 13C NMR (DEPT) spectral data. It gave pos-
itive ferric reaction for phenol and also answered for quinone
by giving bluish pink colour with alcoholic NaOH. The UV
spectrum showed maxima at 222,246,272,316 and 439. The
IR spectrum similarly showed the presence of hydroxyl
(3429 cm1) and only chelated quinone carbonyl
(1630 cm1). The small peak corresponding to unchelated qui-
none carbonyl which appears around 1664 cm1 in anthraqui-
nones (Thomason, 1977) was absent.
Compound was shown to be dimer of compound
(Duraipandiyan et al., 2014), linked at C-6 by its 1H and 13C
NMR spectra. The two meta linked aromatic proton H-2
and H-4 adjacent to the hydroxyl methyl group appeared as
unresolved broad singlet as usual at d 7.27 and 7.65. H-8
appeared as singlet d 7.32. The methylene proton of the hydro-
xyl methyl group at C-3 appeared as broad singlet at d 4.60.
The chelated hydroxyl groups appeared at d 12.22 and 12.76.
The unchelated hydroxyl groups at C-7 appeared at d 11.86.
In the 13C NMR spectrum the linkage of C-6 and C-61 in
the dimeric structure of isolated compound is evident since
C-6 appeared as a singlet in compound and moved down field
to d 112.86 from d 107.88. It is also found that C-5 and C-7
undergo a slight upfield shift.
Isolated compound 6,61-bis (1,5,7-trihydroxy-3-hydroxyme
thylanthraquinone) is new anthraquinone hitherto unreported
from fungi, insects, plants and microbes. The oxynation pat-
tern of the compound does not relate to anthraquinones from
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Figure 1 HPLC chromatogram of compound 6,61-bis (1,5,7-trihydroxy-3-hydroxymethylanthraquinone).
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Figure 2 Structure of the isolated compound 6,61-bis (1,5,7-
trihydroxy-3-hydroxylmethylanthraquinone).
Table 1 Minimum inhibitory concentrations of compound
(6,61-bis (1,5,7-trihydroxy-3-hydroxylmethylanthraquinone)
tested microbes.
Tested organisms Tested compounds standard
Bacteria C Streptomycin
Staphylococcus aureus 62.5 <0.78
Staphylococcus epidermidis 15.62 6.25
Bacillus subtilis 62.5 <0.78
Pseudomonas aeruginosa 150 25
Escherichia coli >250 6.25
Klebsiella pneumoniae >250 <0.78
Enterococcus faecalis 62.5 6.25
Proteus vulgaris >250 25
Fungi Fluconazole
Trichophyton mentagrophytes 15.62 25
Epidermophyton floccosum 125 12.5
Trichophyton rubrum 296 62.5 <12.5
Trichophyton rubrum 57/01 7.81 25
Trichophyton simii 15.62 <12.5
Curvularia lunata >250 <12.5
Aspergiller flavus 3.90 25
Magnaporthe grisea 15.62 >100
Botrytis cinerea 3.90 25
Aspergillus niger 7.81 100
Candida albicans 125 >100
Compound: 6,61-bis (1,5,7-trihydroxy-3-hydroxylmethylanthraquinone).
Standard: Streptomycin (antibacterial agent), Fluconazole (anti-
fungal agent).
734 V. Duraipandiyan et al.the plant, microbes and insect. It is interesting to observe how-
ever that recently many reports showed that plant anthraqui-
nones have been reported from Streptomycetes (Cui et al.,
2008). Many researchers have reported anthraquinones from
actinomycetes. For instance, Cui et al.(2006) have reported
that two anthraquinones (Aloesaponarin II and 1,6-dihy
droxy-8-hydroxymethylanthraquinone) were isolated from
marine Actinomycete isolate M097.
Two novel anthraquinones, were isolated from culture of
Micromonospora sp. named a as lupinacidins A (Ia) and B
(Ib), are isolated and Lupinacidins show significant inhibitory
effects on the invasion of murine colon 26-L5 carcinoma cells
without inhibiting cell growth (Igarashi et al., 2007).
Increasing emergence of resistant pathogens emphasizes the
need for new and effective antimicrobials. In this investigation,
many actinomycete isolates are competent of producing
antimicrobial compounds, active against various infectious
diseases causing resistant bacteria (Yoo et al., 2007; Sohng
et al., 2008; Mellouli et al., 2003). The isolated compound from
Streptomyces sp. ERI 26 inhibited the growth of P. aeruginosa
at 150 lg /ml. The same organism P. aeruginosa was inhibited
by the Streptomyces sp.KH003 at 50 mg /ml of crude extracts.
Seung Sik Cho et al., 2012, reported newly isolated Strepto-
myces sp. CS392 producing antimicrobial compounds which
were active against pathogenic microbes.
Previously we have reported an anthraquinone
2,3-dihydroxy-9,10-anthraquinone isolated from Streptomyces
galbus ERINLG-127 ethyl acetate extract which showed goodantimicrobial activity against tested bacteria and fungi. The
compound showed significant MIC values of 12.5 lg/mL
against P. aeruginosa, Salmonella typhimurium, K. pneumoniae
(ESBL-3894), K. pneumoniae (ESBL-3971), and S. aureus
(MRSA) (Balachandran et al., 2014).
Poumale et al. (2006) reported that new anthraquinone iso-
lated from marine Streptomyces sp. which is named as 8-hyd
roxy-3-methoxy-1-propylanthraquinone and 3,8-dihydroxy-1-
propylanthraquinone and the compound showed activity
against bacteria at a concentration of 40 lg/ml.
Antimicrobial anthraquinone 6,61-bis (1,5,7-trihydroxy-3-hydroxymethylanthraquinone) 7354. Conclusion
The present report is about the isolated novel antimicrobial
anthraquinone from Streptomyces sp. ERI 26, compound
6,61-bis (1,5,7-trihydroxy-3-hydroxymethylanthraquinone
showed good antimicrobial activity.
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